Return to Vaccination News Home Page
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
http://www.nimh.nih.gov/events/prautismcenters.cfm
|
![]() |
|
|
||
| National Institutes of Health | National Institute of Mental Health | |
| |
||
| May 13, 2003 | Contact: Constance Burr NIMH Press Office 301-443-4536 NIMHpress@nih.gov |
|
The National Institutes of Health (NIH) has awarded grants to support six new research centers of a major network focusing on the biomedical and behavioral aspects of autism. These centers will join two that were funded last year. The overall initiative, called STAART (Studies to Advance Autism Research and Treatment) Centers Program, demonstrates NIH commitment to autism research and responds to a need expressed in the Children’s Health Act of 2000.
NIH expects to spend $65 million over five years for the eight centers. STAART is funded by the NIH Autism Coordinating Committee (NIH/ACC), which coordinates autism research conducted by its five member Institutes: The National Institute of Mental Health (NIMH), the National Institute of Child Health and Human Development (NICHD), the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Deafness and Other Communication Disorders (NIDCD), and the National Institute of Environmental Health Sciences (NIEHS).
Each STAART center will contribute to understanding the underlying brain abnormalities, causes, diagnosis, early detection, prevention, and treatment of individuals with autism. All of these areas are crucial to learning more about autism, a brain disorder that affects social, communicative and behavioral functioning from an early age.
Thomas Insel, M.D., NIMH Director and Chair of the Interagency Autism Coordinating Committee (IACC) stated, “This major network of centers will accelerate advances in our knowledge about autism causes and treatments and help us achieve our mission of reducing the burden associated with autism spectrum disorders.”
The six new centers, their directors, and this year’s grant amounts are: University of Washington, Geraldine Dawson, Ph.D., $1.6 million; University of California, Los Angeles, Marian Sigman, Ph.D., $1.4 million; Boston University, Helen Tager-Flusberg, Ph.D., $1.7 million; University of Rochester, Patricia Rodier, Ph.D., $1.5 million; Kennedy Krieger Institute, Rebecca Landa, Ph.D., $1.5 million; and Mt. Sinai Medical School, Eric Hollander, M.D., $1.6 million.
They join the two STAART centers funded last year at the University of North Carolina, Chapel Hill, directed by Joseph Piven, M.D., and at Yale University, directed by Fred Volkmar, M.D.
Plans for collaborative projects include multisite clinical trials within the STAART network, as well as interaction with the Collaborative Programs of Excellence in Autism (CPEA), ten major research programs funded by the NICHD/NIDCD Network on the Neurobiology and Genetics of Autism. A data coordination center will be responsible for both CPEA and STAART networks. Previous funding for the STAART Centers program included one-year developmental grants funded at six universities and research institutes to help research teams prepare applications for future centers.
NIH is the United States Government’s primary agency for biomedical and behavioral research, and is part of the Department of Health and Human Services.
Posted: May 13, 2003
| NIMH Home |
Welcome |
News and Events
| Clinical
Trials |
Funding Opportunities | |
For information about NIMH and its programs, please email, write or phone us. National Institute of Mental Health (NIMH) Se Habla Español
|
|
and Human Services |
9000 Rockville Pike Bethesda, Maryland 20892 |
|
Return to Vaccination News Home Page
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.